Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Journal of Computational Chemistry
|
February 19, 2010
Multiple ligand simultaneous docking: orchestrated dancing of ligands in binding sites of protein
Huameng Li, Chenglong Li
Nature Protocols
|
June 23, 2007
Robust analysis of 5'-transcript ends: a high-throughput protocol for characterization of sequence diversity of transcription start sites
Malali Gowda, Huameng Li, Guo-Liang Wang
Biochemical and Biophysical Research Communications
|
March 15, 2011
Celecoxib inhibits STAT3 phosphorylation and suppresses cell migration and colony forming ability in rhabdomyosarcoma cells
Suzanne Reed, Huameng Li, Chenglong Li, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
April 15, 2011
Celecoxib inhibits interleukin-6/interleukin-6 receptor-induced JAK2/STAT3 phosphorylation in human hepatocellular carcinoma cells
Yan Liu, Aiguo Liu, Huameng Li, et al.
Trends in Pharmacological Sciences
|
November 19, 2015
Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism
Chengguang Zhao, Huameng Li, Huey-Jen Lin, et al.
Journal of Medicinal Chemistry
|
June 18, 2011
Fragment-based drug design and drug repositioning using multiple ligand simultaneous docking (MLSD): identifying celecoxib and template compounds as novel inhibitors of signal transducer and activator of transcription 3 (STAT3)
Huameng Li, Aiguo Liu, Zhenjiang Zhao, et al.
Journal of Medicinal Chemistry
|
January 25, 2014
Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 interface
Huameng Li, Hui Xiao, Li Lin, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 25, 2019
Correction to: Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
Jia Wei, Ling Ma, Yi-Hui Lai, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 10, 2019
Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
Jia Wei, Ling Ma, Yi-Hui Lai, et al.
Plos One
|
December 12, 2025
Investigation of the effect and mechanisms of moxa smoke in the treatment of Influenza A Virus (IAV) infection
Ting Cao, Wenchao Pan, Ziyao Liang, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Journal of Computational Chemistry
|
February 19, 2010
Multiple ligand simultaneous docking: orchestrated dancing of ligands in binding sites of protein
Huameng Li, Chenglong Li
Nature Protocols
|
June 23, 2007
Robust analysis of 5'-transcript ends: a high-throughput protocol for characterization of sequence diversity of transcription start sites
Malali Gowda, Huameng Li, Guo-Liang Wang
Biochemical and Biophysical Research Communications
|
March 15, 2011
Celecoxib inhibits STAT3 phosphorylation and suppresses cell migration and colony forming ability in rhabdomyosarcoma cells
Suzanne Reed, Huameng Li, Chenglong Li, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
April 15, 2011
Celecoxib inhibits interleukin-6/interleukin-6 receptor-induced JAK2/STAT3 phosphorylation in human hepatocellular carcinoma cells
Yan Liu, Aiguo Liu, Huameng Li, et al.
Trends in Pharmacological Sciences
|
November 19, 2015
Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism
Chengguang Zhao, Huameng Li, Huey-Jen Lin, et al.
Journal of Medicinal Chemistry
|
June 18, 2011
Fragment-based drug design and drug repositioning using multiple ligand simultaneous docking (MLSD): identifying celecoxib and template compounds as novel inhibitors of signal transducer and activator of transcription 3 (STAT3)
Huameng Li, Aiguo Liu, Zhenjiang Zhao, et al.
Journal of Medicinal Chemistry
|
January 25, 2014
Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 interface
Huameng Li, Hui Xiao, Li Lin, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 25, 2019
Correction to: Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
Jia Wei, Ling Ma, Yi-Hui Lai, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 10, 2019
Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
Jia Wei, Ling Ma, Yi-Hui Lai, et al.
Plos One
|
December 12, 2025
Investigation of the effect and mechanisms of moxa smoke in the treatment of Influenza A Virus (IAV) infection
Ting Cao, Wenchao Pan, Ziyao Liang, et al.
Page
of 3